NCT00603291View on ClinicalTrials.gov

BLOOM-DM: Behavioral Modification and Lorcaserin for Overweight and Obesity Management in Diabetes Mellitus

PHASE3CompletedINTERVENTIONAL
Enrollment

604

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

June 30, 2010

Study Completion Date

October 31, 2010

Conditions
Obesity
Interventions
DRUG

Lorcaserin 10 mg once daily (QD)

Lorcaserin 10 mg tablet each morning and placebo tablet each evening for a duration of 52 weeks.

DRUG

Lorcaserin 10 mg twice a day (BID)

Lorcaserin 10 mg tablet each morning and evening for a duration of 52 weeks.

DRUG

Matching Placebo

Matching placebo tablet each morning and evening for a duration of 52 weeks.

Trial Locations (1)

92121

Arena Pharmaceuticals, Inc., San Diego

All Listed Sponsors
lead

Eisai Inc.

INDUSTRY

NCT00603291 - BLOOM-DM: Behavioral Modification and Lorcaserin for Overweight and Obesity Management in Diabetes Mellitus | Biotech Hunter | Biotech Hunter